-
1
-
-
77649126524
-
Heart disease and stroke statistics - 2010 update: A report from the American Heart Association
-
Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 2010;121:e46-215.
-
(2010)
Circulation
, vol.121
-
-
Lloyd-Jones, D.1
Adams, R.J.2
Brown, T.M.3
-
2
-
-
0034888004
-
Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: A 20-year experience
-
DOI 10.1016/S0735-1097(01)01349-3, PII S0735109701013493
-
Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol 2001;38:409-14. (Pubitemid 32721768)
-
(2001)
Journal of the American College of Cardiology
, vol.38
, Issue.2
, pp. 409-414
-
-
Suero, J.A.1
Marso, S.P.2
Jones, P.G.3
Laster, S.B.4
Huber, K.C.5
Giorgi, L.V.6
Johnson, W.L.7
Rutherford, B.D.8
-
3
-
-
49449104281
-
Acute myocardial infarction
-
White HD, Chew DP. Acute myocardial infarction. Lancet 2008;372:570-84.
-
(2008)
Lancet
, vol.372
, pp. 570-84
-
-
White, H.D.1
Chew, D.P.2
-
5
-
-
0037206364
-
Long-term trends in the incidence of and survival with heart failure
-
DOI 10.1056/NEJMoa020265
-
Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-402. (Pubitemid 35239711)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.18
, pp. 1397-1402
-
-
Levy, D.1
Kenchaiah, S.2
Glarson, M.3
Benjamin, E.J.4
Kupka, M.5
Ho, K.K.L.6
Murabito, J.M.7
Vasan, R.S.8
-
6
-
-
2442441133
-
Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
-
DOI 10.1016/j.jacc.2003.09.071, PII S0735109704004668
-
Kernis SJ, Harjai KJ, Stone GW, et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J Am Coll Cardiol 2004;43:1773-9. (Pubitemid 38622513)
-
(2004)
Journal of the American College of Cardiology
, vol.43
, Issue.10
, pp. 1773-1779
-
-
Kernis, S.J.1
Harjai, K.J.2
Stone, G.W.3
Grines, L.L.4
Boura, J.A.5
O'Neill, W.W.6
Grines, C.L.7
-
7
-
-
38349006586
-
Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: Findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial
-
Pedrazzini G, Santoro E, Latini R, et al. Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial. Am Heart J 2008;155:388-94.
-
(2008)
Am Heart J
, vol.155
, pp. 388-94
-
-
Pedrazzini, G.1
Santoro, E.2
Latini, R.3
-
8
-
-
3142745348
-
Trends in heart failure incidence and survival in a community-based population
-
DOI 10.1001/jama.292.3.344
-
Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50. (Pubitemid 38944258)
-
(2004)
Journal of the American Medical Association
, vol.292
, Issue.3
, pp. 344-350
-
-
Roger, V.L.1
Weston, S.A.2
Redfield, M.M.3
Hellermann-Homan, J.P.4
Killian, J.5
Yawn, B.P.6
Jacobsen, S.J.7
-
9
-
-
55949108787
-
Designing heart performance by gene transfer
-
Davis J, Westfall MV, Townsend D, et al. Designing heart performance by gene transfer. Physiol Rev 2008;88:1567-651.
-
(2008)
Physiol Rev
, vol.88
, pp. 1567-651
-
-
Davis, J.1
Westfall, M.V.2
Townsend, D.3
-
10
-
-
0037188561
-
Myocardial regeneration therapy for heart failure: Hepatocyte growth factor enhances the effect of cellular cardiomyoplasty
-
DOI 10.1161/01.CIR.0000016722.37138.F2
-
Miyagawa S, Sawa Y, Taketani S, et al. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 2002;105:2556-61. (Pubitemid 34568980)
-
(2002)
Circulation
, vol.105
, Issue.21
, pp. 2556-2561
-
-
Miyagawa, S.1
Sawa, Y.2
Taketani, S.3
Kawaguchi, N.4
Nakamura, T.5
Matsuura, N.6
Matsuda, H.7
-
11
-
-
0041876318
-
Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer
-
DOI 10.1038/sj.gt.3302034
-
Lee M, Rentz J, Bikram M, et al. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther 2003;10:1535-42. (Pubitemid 37063258)
-
(2003)
Gene Therapy
, vol.10
, Issue.18
, pp. 1535-1542
-
-
Lee, M.1
Rentz, J.2
Bikram, M.3
Han, S.4
Bull, D.A.5
Kim, S.W.6
-
12
-
-
10744219542
-
Adrenomedullin Gene Transfer Induces Therapeutic Angiogenesis in a Rabbit Model of Chronic Hind Limb Ischemia: Benefits of a Novel Nonviral Vector, Gelatin
-
DOI 10.1161/01.CIR.0000109700.81266.32
-
Tokunaga N, Nagaya N, Shirai M, et al. Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia: benefits of a novel nonviral vector, gelatin. Circulation 2004;109:526-31. (Pubitemid 38168517)
-
(2004)
Circulation
, vol.109
, Issue.4
, pp. 526-531
-
-
Tokunaga, N.1
Nagaya, N.2
Shirai, M.3
Tanaka, E.4
Ishibashi-Ueda, H.5
Harada-Shiba, M.6
Kanda, M.7
Ito, T.8
Shimizu, W.9
Tabata, Y.10
Uematsu, M.11
Nishigami, K.12
Sano, S.13
Kangawa, K.14
Mori, H.15
-
13
-
-
16544377151
-
Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer
-
Pitard B, Bello-Roufai M, Lambert O, et al. Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer. Nucleic Acids Res 2004;32:e159
-
(2004)
Nucleic Acids Res
, vol.32
-
-
Pitard, B.1
Bello-Roufai, M.2
Lambert, O.3
-
14
-
-
0035078206
-
Augmentation of myocardial transfection using TerplexDNA: A novel gene delivery system
-
DOI 10.1038/sj.gt.3301395
-
Affleck DG, Yu L, Bull DA, et al. Augmentation of myocardial transfection using TerplexDNA: a novel gene delivery system. Gene Ther 2001;8:349-53. (Pubitemid 32241934)
-
(2001)
Gene Therapy
, vol.8
, Issue.5
, pp. 349-353
-
-
Affleck, D.G.1
Yu, L.2
Bull, D.A.3
Bailey, S.H.4
Kim, S.W.5
-
15
-
-
76849097642
-
Nonviral intercellular adhesion molecule-1 small interfering ribonucleic acid sequences transfection in vivo how ultrasound bursts into therapy
-
Kupatt C. Nonviral intercellular adhesion molecule-1 small interfering ribonucleic acid sequences transfection in vivo how ultrasound bursts into therapy. J Am Coll Cardiol 2010;55:914-16.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 914-16
-
-
Kupatt, C.1
-
17
-
-
77951956539
-
Cellular endocytosis and gene delivery
-
Ziello JE, Huang Y, Jovin IS. Cellular endocytosis and gene delivery. Mol Med 2010;16:222-9.
-
(2010)
Mol Med
, vol.16
, pp. 222-9
-
-
Ziello, J.E.1
Huang, Y.2
Jovin, I.S.3
-
18
-
-
0038745599
-
Progress and problems with the use of viral vectors for gene therapy
-
DOI 10.1038/nrg1066
-
Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4:346-58. (Pubitemid 36538359)
-
(2003)
Nature Reviews Genetics
, vol.4
, Issue.5
, pp. 346-358
-
-
Thomas, C.E.1
Ehrhardt, A.2
Kay, M.A.3
-
19
-
-
0031916435
-
Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
-
DOI 10.1038/ng0298-180
-
Schiedner G, Morral N, Parks RJ, et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 1998;18:180-3. (Pubitemid 28082470)
-
(1998)
Nature Genetics
, vol.18
, Issue.2
, pp. 180-183
-
-
Schiedner, G.1
Morral, N.2
Parks, R.J.3
Wu, Y.4
Koopmans, S.C.5
Langston, C.6
Graham, F.L.7
Beaudet, A.L.8
Kochanek, S.9
-
20
-
-
27544511553
-
Gutted adenovirus: A rising star on the horizon?
-
DOI 10.1038/sj.gt.3302597, PII 3302597
-
Ehrhardt A, Kay MA. Gutted adenovirus: a rising star on the horizon? Gene Ther 2005;12:1540-1. (Pubitemid 41541770)
-
(2005)
Gene Therapy
, vol.12
, Issue.21
, pp. 1540-1541
-
-
Ehrhardt, A.1
Kay, M.A.2
-
21
-
-
11144248909
-
The innate immune response to adenovirus vectors
-
Muruve DA. The innate immune response to adenovirus vectors. Hum Gene Ther 2004;15:1157-66. (Pubitemid 40052429)
-
(2004)
Human Gene Therapy
, vol.15
, Issue.12
, pp. 1157-1166
-
-
Muruve, D.A.1
-
22
-
-
2642512201
-
Clades of adeno-associated viruses are widely disseminated in human tissues
-
DOI 10.1128/JVI.78.12.6381-6388.2004
-
Gao G, Vandenberghe LH, Alvira MR, et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol 2004;78:6381-8. (Pubitemid 38715936)
-
(2004)
Journal of Virology
, vol.78
, Issue.12
, pp. 6381-6388
-
-
Gao, G.1
Vandenberghe, L.H.2
Alvira, M.R.3
Lu, Y.4
Calcedo, R.5
Zhou, X.6
Wilson, J.M.7
-
23
-
-
0029858907
-
Site-specific integration by adeno-associated virus
-
DOI 10.1073/pnas.93.21.11288
-
Linden RM, Ward P, Giraud C, et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1996;93:11288-94. (Pubitemid 26347114)
-
(1996)
Proceedings of the National Academy of Sciences of the United States of America
, vol.93
, Issue.21
, pp. 11288-11294
-
-
Linden, R.M.1
Ward, P.2
Giraud, C.3
Winocour, E.4
Berns, K.I.5
-
24
-
-
0742324064
-
Gene therapy for cardiovascular diseases
-
DOI 10.2174/1381612043453379
-
Gruchala M, Roy H, Bhardwaj S, Yla-Herttuala S. Gene therapy for cardiovascular diseases. Curr Pharm Des 2004;10:407-23. (Pubitemid 38159871)
-
(2004)
Current Pharmaceutical Design
, vol.10
, Issue.4
, pp. 407-423
-
-
Gruchala, M.1
Roy, H.2
Bhardwaj, S.3
Yla-Herttuala, S.4
-
25
-
-
0037022253
-
Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene
-
DOI 10.1161/hc0502.103363
-
Melo LG, Agrawal R, Zhang L, et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002;105:602-7. (Pubitemid 34123435)
-
(2002)
Circulation
, vol.105
, Issue.5
, pp. 602-607
-
-
Melo, L.G.1
Agrawal, R.2
Zhang, L.3
Rezvani, M.4
Mangi, A.A.5
Ehsan, A.6
Griese, D.P.7
Dell'Acqua, G.8
Mann, M.J.9
Oyama, J.10
Yet, S.-F.11
Layne, M.D.12
Perrella, M.A.13
Dzau, V.J.14
-
26
-
-
0036341380
-
Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery
-
Hoshijima M, Ikeda Y, Iwanaga Y, et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 2002;8:864-71.
-
(2002)
Nat Med
, vol.8
, pp. 864-71
-
-
Hoshijima, M.1
Ikeda, Y.2
Iwanaga, Y.3
-
27
-
-
37749013444
-
Gene therapy: Targeting the myocardium
-
Lyon AR, Sato M, Hajjar RJ, et al. Gene therapy: targeting the myocardium. Heart 2008;94:89-99.
-
(2008)
Heart
, vol.94
, pp. 89-99
-
-
Lyon, A.R.1
Sato, M.2
Hajjar, R.J.3
-
28
-
-
33747518710
-
Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo
-
DOI 10.1161/01.RES.0000237661.18885.f6, PII 0000301220060818000019
-
Pacak CA, Mah CS, Thattaliyath BD, et al. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ Res 2006;99:e3-9. (Pubitemid 44255502)
-
(2006)
Circulation Research
, vol.99
, Issue.4
-
-
Pacak, C.A.1
Mah, C.S.2
Thattaliyath, B.D.3
Conlon, T.J.4
Lewis, M.A.5
Cloutier, D.E.6
Zolotukhin, I.7
Tarantal, A.F.8
Byrne, B.J.9
-
29
-
-
62649151797
-
A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
-
Yang L, Jiang JG, Drouin LM, et al. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection. Proc Natl Acad Sci USA 2009;106:3946-51.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 3946-51
-
-
Yang, L.1
Jiang, J.G.2
Drouin, L.M.3
-
30
-
-
74049120342
-
Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle
-
Asokan A, Conway JC, Phillips JL, et al. Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nat Biotech 2010;28:79-82.
-
(2010)
Nat Biotech
, vol.28
, pp. 79-82
-
-
Asokan, A.1
Conway, J.C.2
Phillips, J.L.3
-
31
-
-
65249108107
-
Preventing and exploiting the oncogenic potential of integrating gene vectors
-
Modlich U, Baum C. Preventing and exploiting the oncogenic potential of integrating gene vectors. J Clin Invest 2009;119:755-8.
-
(2009)
J Clin Invest
, vol.119
, pp. 755-8
-
-
Modlich, U.1
Baum, C.2
-
32
-
-
65249101260
-
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
-
Montini E, Cesana D, Schmidt M, et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 2009;119:964-75.
-
(2009)
J Clin Invest
, vol.119
, pp. 964-75
-
-
Montini, E.1
Cesana, D.2
Schmidt, M.3
-
33
-
-
0032553469
-
Gene therapy Treating with HIV
-
Sikorski R, Peters R. Gene therapy. Treating with HIV. Science 1998;282:1438.
-
(1998)
Science
, vol.282
, pp. 1438
-
-
Sikorski, R.1
Peters, R.2
-
34
-
-
0033618547
-
Lentiviral vectors - The promise of gene therapy within reach?
-
Amado RG, Chen IS. Lentiviral vectors - the promise of gene therapy within reach? Science 1999;285:674-6.
-
(1999)
Science
, vol.285
, pp. 674-6
-
-
Amado, R.G.1
Chen, I.S.2
-
35
-
-
0038742916
-
'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo
-
DOI 10.1038/sj.gt.3301936
-
Bonci D, Cittadini A, Latronico MV, et al. 'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther 2003;10:630-6. (Pubitemid 36553608)
-
(2003)
Gene Therapy
, vol.10
, Issue.8
, pp. 630-636
-
-
Bonci, D.1
Cittadini, A.2
Latronico, M.V.G.3
Borello, U.4
Aycock, J.K.5
Drusco, A.6
Innocenzi, A.7
Follenzi, A.8
Lavitrano, M.9
Monti, M.G.10
Ross Jr., J.11
Naldini, L.12
Peschle, C.13
Cossu, G.14
Condorelli, G.15
-
36
-
-
33646241297
-
Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro
-
Simmons A, Whitehead RP, Kolokoltsov AA, Davey RA. Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro. Virol J 2006;3:8
-
(2006)
Virol J
, vol.3
, pp. 8
-
-
Simmons, A.1
Whitehead, R.P.2
Kolokoltsov, A.A.3
Davey, R.A.4
-
37
-
-
0036732734
-
Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo
-
Zhao J, Pettigrew GJ, Thomas J, et al. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol 2002;97:348-58.
-
(2002)
Basic Res Cardiol
, vol.97
, pp. 348-58
-
-
Zhao, J.1
Pettigrew, G.J.2
Thomas, J.3
-
38
-
-
0038663005
-
Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo
-
DOI 10.1161/01.CIR.0000065598.46411.EF
-
Fleury S, Simeoni E, Zuppinger C, et al. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo. Circulation 2003;107:2375-82. (Pubitemid 36578511)
-
(2003)
Circulation
, vol.107
, Issue.18
, pp. 2375-2382
-
-
Fleury, S.1
Simeoni, E.2
Zuppinger, C.3
Deglon, N.4
Von Segesser, L.K.5
Kappenberger, L.6
Vassalli, G.7
-
39
-
-
0035135747
-
Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics
-
DOI 10.1038/83324
-
Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001;7:33-40. (Pubitemid 32095639)
-
(2001)
Nature Medicine
, vol.7
, Issue.1
, pp. 33-40
-
-
Kay, M.A.1
Glorioso, J.C.2
Naldini, L.3
-
40
-
-
10644279947
-
Vascular endothelial growth factor and angiogenesis
-
DOI 10.1124/pr.56.4.3
-
Hoeben A, Landuyt B, Highley MS, et al. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004;56:549-80. (Pubitemid 39658463)
-
(2004)
Pharmacological Reviews
, vol.56
, Issue.4
, pp. 549-580
-
-
Hoeben, A.1
Landuyt, B.2
Highley, M.S.3
Wildiers, H.4
Van Oosterom, A.T.5
De Bruijn, E.A.6
-
41
-
-
0030004485
-
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
-
DOI 10.1038/380439a0
-
Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-42. (Pubitemid 26102720)
-
(1996)
Nature
, vol.380
, Issue.6573
, pp. 439-442
-
-
Ferrara, N.1
Carver-Moore, K.2
Chen, H.3
Dowd, M.4
Lu, L.5
O'Shea, K.S.6
Powell-Braxton, L.7
Hillan, K.J.8
Moore, M.W.9
-
42
-
-
25444463573
-
Endothelial/pericyte interactions
-
DOI 10.1161/01.RES.0000182903.16652.d7
-
Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005;97:512-23. (Pubitemid 41361741)
-
(2005)
Circulation Research
, vol.97
, Issue.6
, pp. 512-523
-
-
Armulik, A.1
Abramsson, A.2
Betsholtz, C.3
-
43
-
-
0032578961
-
165 as sole therapy for myocardial ischemia
-
Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998;98:2800-4. (Pubitemid 29003959)
-
(1998)
Circulation
, vol.98
, Issue.25
, pp. 2800-2804
-
-
Losordo, D.W.1
Vale, P.R.2
Symes, J.F.3
Dunnington, C.H.4
Esakof, D.D.5
Maysky, M.6
Ashare, A.B.7
Lathi, K.8
Isner, J.M.9
-
44
-
-
0037197740
-
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia
-
DOI 10.1161/01.CIR.0000015982.70785.B7
-
Losordo DW, Vale PR, Hendel RC, et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002;105:2012-18. (Pubitemid 34465261)
-
(2002)
Circulation
, vol.105
, Issue.17
, pp. 2012-2018
-
-
Losordo, D.W.1
Vale, P.R.2
Hendel, R.C.3
Milliken, C.E.4
Fortuin, F.D.5
Cummings, N.6
Schatz, R.A.7
Asahara, T.8
Isner, J.M.9
Kuntz, R.E.10
-
45
-
-
67349287066
-
VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: Results of the NORTHERN trial
-
Stewart DJ, Kutryk MJB, Fitchett D, et al. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol Ther 2009;17:1109-15.
-
(2009)
Mol Ther
, vol.17
, pp. 1109-15
-
-
Stewart, D.J.1
Mjb, K.2
Fitchett, D.3
-
46
-
-
0038210219
-
Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio angiogenesis trial (KAT)
-
Hedman M, Hartikainen J, Syvanne M, et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003;107:2677-83. (Pubitemid 36667240)
-
(2003)
Circulation
, vol.107
, Issue.21
, pp. 2677-2683
-
-
Hedman, M.1
Hartikainen, J.2
Syvanne, M.3
Stjernvall, J.4
Hedman, A.5
Kivela, A.6
Vanninen, E.7
Mussalo, H.8
Kauppila, E.9
Simula, S.10
Narvanen, O.11
Rantala, A.12
Peuhkurinen, K.13
Nieminen, M.S.14
Laakso, M.15
Yla-Herttuala, S.16
-
47
-
-
33748155036
-
121 (AdVEGF121) versus maximum medical treatment
-
DOI 10.1038/sj.gt.3302802, PII 3302802
-
Stewart DJ, Hilton JD, Arnold JM, et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment. Gene Ther 2006;13:1503-11. (Pubitemid 44574158)
-
(2006)
Gene Therapy
, vol.13
, Issue.21
, pp. 1503-1511
-
-
Stewart, D.J.1
Hilton, J.D.2
Arnold, J.M.O.3
Gregoire, J.4
Rivard, A.5
Archer, S.L.6
Charbonneau, F.7
Cohen, E.8
Curtis, M.9
Buller, C.E.10
Mendelsohn, F.O.11
Dib, N.12
Page, P.13
Ducas, J.14
Plante, S.15
Sullivan, J.16
Macko, J.17
Rasmussen, C.18
Kessler, P.D.19
Rasmussen, H.S.20
more..
-
48
-
-
79954490234
-
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: The NOVA trial
-
Kastrup J, Jorgensen E, Fuchs S, et al. A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial. EuroIntervention 2011;6:813-18.
-
(2011)
EuroIntervention
, vol.6
, pp. 813-18
-
-
Kastrup, J.1
Jorgensen, E.2
Fuchs, S.3
-
49
-
-
33747488429
-
An update on angiogenic gene therapy: Vascular endothelial growth factor and other directions
-
Yla-Herttuala S. An update on angiogenic gene therapy: vascular endothelial growth factor and other directions. Curr Opin Mol Ther 2006;8:295-300. (Pubitemid 44256363)
-
(2006)
Current Opinion in Molecular Therapeutics
, vol.8
, Issue.4
, pp. 295-300
-
-
Yla-Herttuala, S.1
-
50
-
-
0036789313
-
The role of fibroblast growth factors in vascular development
-
Javerzat S, Auguste P, Bikfalvi A. The role of fibroblast growth factors in vascular development. Trends Mol Med 2002;8:483-9.
-
(2002)
Trends Mol Med
, vol.8
, pp. 483-9
-
-
Javerzat, S.1
Auguste, P.2
Bikfalvi, A.3
-
51
-
-
0029877965
-
Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart
-
DOI 10.1038/nm0596-534
-
Giordano FJ, Ping P, McKirnan MD, et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 1996;2:534-9. (Pubitemid 26151517)
-
(1996)
Nature Medicine
, vol.2
, Issue.5
, pp. 534-539
-
-
Giordano, F.J.1
Ping, P.2
Dan Mckirnan, M.3
Nozaki, S.4
DeMaria, A.N.5
Dillmann, W.H.6
Mathieu-Costello, O.7
Hammond, H.K.8
-
52
-
-
0242459072
-
Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): A new option for the treatment of coronary artery disease
-
DOI 10.1016/S0002-9149(03)00965-2
-
Grines C, Rubanyi GM, Kleiman NS, et al. Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease. Am J Cardiol 2003;92:24N-31N. (Pubitemid 37412348)
-
(2003)
American Journal of Cardiology
, vol.92
, Issue.9 SUPPL. 2
-
-
Grines, C.1
Rubanyi, G.M.2
Kleiman, N.S.3
Marrott, P.4
Watkins, M.W.5
-
53
-
-
0037133624
-
Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris
-
DOI 10.1161/hc1102.105595
-
Grines CL, Watkins MW, Helmer G, et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002;105:1291-7. (Pubitemid 34260418)
-
(2002)
Circulation
, vol.105
, Issue.11
, pp. 1291-1297
-
-
Grines, C.L.1
Watkins, M.W.2
Helmer, G.3
Penny, W.4
Brinker, J.5
Marmur, J.D.6
West, A.7
Rade, J.J.8
Marrott, P.9
Hammond, H.K.10
Engler, R.L.11
-
54
-
-
34548446034
-
Effects of Ad5FGF-4 in Patients With Angina. An Analysis of Pooled Data From the AGENT-3 and AGENT-4 Trials
-
DOI 10.1016/j.jacc.2007.06.010, PII S0735109707019997
-
Henry TD, Grines CL, Watkins MW, et al. Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J Am Coll Cardiol 2007;50:1038-46. (Pubitemid 47354223)
-
(2007)
Journal of the American College of Cardiology
, vol.50
, Issue.11
, pp. 1038-1046
-
-
Henry, T.D.1
Grines, C.L.2
Watkins, M.W.3
Dib, N.4
Barbeau, G.5
Moreadith, R.6
Andrasfay, T.7
Engler, R.L.8
-
55
-
-
0032889971
-
Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development
-
Carmeliet P, Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Top Microbiol Immunol 1999;237:133-58. (Pubitemid 28554862)
-
(1999)
Current Topics in Microbiology and Immunology
, vol.237
, pp. 133-158
-
-
Carmeliet, P.1
Collen, D.2
-
56
-
-
0037090776
-
Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy
-
DOI 10.1093/emboj/21.8.1939
-
Dor Y, Djonov V, Abramovitch R, et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 2002;21:1939-47. (Pubitemid 34437191)
-
(2002)
EMBO Journal
, vol.21
, Issue.8
, pp. 1939-1947
-
-
Dor, Y.1
Djonov, V.2
Abramovitch, R.3
Itin, A.4
Fishman, G.I.5
Carmeliet, P.6
Goelman, G.7
Keshets, E.8
-
57
-
-
77955285388
-
Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion: Role of vessel maturation
-
Kupatt C, Hinkel R, Pfosser A, et al. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion: role of vessel maturation. JACC 2010;56:414-22.
-
(2010)
JACC
, vol.56
, pp. 414-22
-
-
Kupatt, C.1
Hinkel, R.2
Pfosser, A.3
-
58
-
-
78649455280
-
Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization
-
Stratman AN, Schwindt AE, Malotte KM, Davis GE. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 2010;116:4720-30
-
(2010)
Blood
, vol.116
, pp. 4720-30
-
-
Stratman, A.N.1
Schwindt, A.E.2
Malotte, K.M.3
Davis, G.E.4
-
59
-
-
0030480322
-
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
-
DOI 10.1016/S0092-8674(00)81813-9
-
Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996;87:1171-80. (Pubitemid 27010101)
-
(1996)
Cell
, vol.87
, Issue.7
, pp. 1171-1180
-
-
Suri, C.1
Jones, P.F.2
Patan, S.3
Bartunkova, S.4
Maisonpierre, P.C.5
Davis, S.6
Sato, T.N.7
Yancopoulos, G.D.8
-
60
-
-
0037689525
-
Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors
-
DOI 10.1016/S1525-0016(03)00034-0
-
Arsic N, Zentilin L, Zacchigna S, et al. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther 2003;7:450-9. (Pubitemid 36553413)
-
(2003)
Molecular Therapy
, vol.7
, Issue.4
, pp. 450-459
-
-
Arsic, N.1
Zentilin, L.2
Zacchigna, S.3
Santoro, D.4
Stanta, G.5
Salvi, A.6
Sinagra, G.7
Giacca, M.8
-
61
-
-
57949098602
-
Collateral circulation past and present
-
Schaper W. Collateral circulation past and present. Basic Res Cardiol 2009;104:5-21.
-
(2009)
Basic Res Cardiol
, vol.104
, pp. 5-21
-
-
Schaper, W.1
-
62
-
-
62149099949
-
Stimulation of collateral artery growth: Travelling further down the road to clinical application
-
Schirmer SH, van Nooijen FC, Piek JJ, van Royen N. Stimulation of collateral artery growth: travelling further down the road to clinical application. Heart 2009;95:191-7.
-
(2009)
Heart
, vol.95
, pp. 191-7
-
-
Schirmer, S.H.1
Van Nooijen, F.C.2
Piek, J.J.3
Van Royen, N.4
-
63
-
-
27444435410
-
Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease
-
DOI 10.1016/j.jacc.2005.01.068, PII S0735109705018395
-
Zbinden S, Zbinden R, Meier P, et al. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1636-42. (Pubitemid 41531615)
-
(2005)
Journal of the American College of Cardiology
, vol.46
, Issue.9
, pp. 1636-1642
-
-
Zbinden, S.1
Zbinden, R.2
Meier, P.3
Windecker, S.4
Seiler, C.5
-
64
-
-
0035908945
-
2+-ATPase in a rat model of heart failure
-
del Monte F, Williams E, Lebeche D, et al. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca2+-ATPase in a rat model of heart failure. Circulation 2001;104:1424-9. (Pubitemid 32880157)
-
(2001)
Circulation
, vol.104
, Issue.12
, pp. 1424-1429
-
-
Del Monte, F.1
Williams, E.2
Lebeche, D.3
Schmidt, U.4
Rosenzweig, A.5
Gwathmey, J.K.6
Lewandowski, E.D.7
Hajjar, R.J.8
-
65
-
-
0037599451
-
Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients
-
DOI 10.1054/jcaf.2003.28
-
Jaski BE, Ha J, Denys BG, et al. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 2003;9:227-31. (Pubitemid 36734320)
-
(2003)
Journal of Cardiac Failure
, vol.9
, Issue.3
, pp. 227-231
-
-
Jaski, B.E.1
Ha, J.2
Denys, B.G.3
Lamba, S.4
Trupp, R.J.5
Abraham, W.T.6
-
66
-
-
0000896661
-
2+-binding protein S100A1 in human cardiomyopathy
-
DOI 10.1016/0167-4889(96)00097-3
-
Remppis A, Greten T, Schafer BW, et al. Altered expression of the Ca2+-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta 1996;1313:253-7. (Pubitemid 26342956)
-
(1996)
Biochimica et Biophysica Acta - Molecular Cell Research
, vol.1313
, Issue.3
, pp. 253-257
-
-
Remppis, A.1
Greten, T.2
Schafer, B.W.3
Hunziker, P.4
Erne, P.5
Katus, H.A.6
Heizmann, C.W.7
-
67
-
-
0036193622
-
Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice
-
DOI 10.1128/MCB.22.8.2821-2829.2002
-
Du XJ, Cole TJ, Tenis N, et al. Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice. Mol Cell Biol 2002;22:2821-9. (Pubitemid 34263002)
-
(2002)
Molecular and Cellular Biology
, vol.22
, Issue.8
, pp. 2821-2829
-
-
Du, X.-J.1
Cole, T.J.2
Tenis, N.3
Gao, X.-M.4
Kontgen, F.5
Kemp, B.E.6
Heierhorst, J.7
-
68
-
-
34248570118
-
Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue
-
DOI 10.1161/CIRCULATIONAHA.106.671701
-
Pleger ST, Most P, Boucher M, et al. Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation 2007;115:2506-15. (Pubitemid 46763224)
-
(2007)
Circulation
, vol.115
, Issue.19
, pp. 2506-2515
-
-
Pleger, S.T.1
Most, P.2
Boucher, M.3
Soltys, S.4
Chuprun, J.K.5
Pleger, W.6
Gao, E.7
Dasgupta, A.8
Rengo, G.9
Remppis, A.10
Katus, H.A.11
Eckhart, A.D.12
Rabinowitz, J.E.13
Koch, W.J.14
-
69
-
-
0034625008
-
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
-
DOI 10.1073/pnas.090091197
-
White DC, Hata JA, Shah AS, et al. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc Natl Acad Sci USA 2000;97:5428-33. (Pubitemid 30313735)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.10
, pp. 5428-5433
-
-
White, D.C.1
Hata, J.A.2
Shah, A.S.3
Glower, D.D.4
Lefkowitz, R.J.5
Koch, W.J.6
-
70
-
-
1842526833
-
Targeted β-Adrenergic Receptor Kinase (βARK1) Inhibition by Gene Transfer in Failing Human Hearts
-
DOI 10.1161/01.CIR.0000125521.40985.28
-
Williams ML, Hata JA, Schroder J, et al. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts. Circulation 2004;109:1590-3. (Pubitemid 38451713)
-
(2004)
Circulation
, vol.109
, Issue.13
, pp. 1590-1593
-
-
Williams, M.L.1
Hata, J.A.2
Schroder, J.3
Rampersaud, E.4
Petrofski, J.5
Jakoi, A.6
Milano, C.A.7
Koch, W.J.8
-
71
-
-
77949419010
-
Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction
-
Sumida A, Horiba M, Ishiguro H, et al. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Cardiovasc Res 2010;86:113-21.
-
(2010)
Cardiovasc Res
, vol.86
, pp. 113-21
-
-
Sumida, A.1
Horiba, M.2
Ishiguro, H.3
-
72
-
-
77649253288
-
MicroRNAs add a new dimension to cardiovascular disease
-
Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010;121:1022-32.
-
(2010)
Circulation
, vol.121
, pp. 1022-32
-
-
Small, E.M.1
Frost, R.J.2
Olson, E.N.3
-
73
-
-
77952349351
-
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure
-
Poller W, Hajjar R, Schultheiss HP, Fechner H. Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure. Cardiovasc Res 2010;86:353-64.
-
(2010)
Cardiovasc Res
, vol.86
, pp. 353-64
-
-
Poller, W.1
Hajjar, R.2
Schultheiss, H.P.3
Fechner, H.4
-
74
-
-
78149355643
-
"locked onto the target": Increasing the efficiency of antagomirzymes using locked nucleic acid modifications
-
Kaur H, Scaria V, Maiti S. "Locked onto the target": increasing the efficiency of antagomirzymes using locked nucleic acid modifications. Biochemistry 2010;49:9449-56
-
(2010)
Biochemistry
, vol.49
, pp. 9449-56
-
-
Kaur, H.1
Scaria, V.2
Maiti, S.3
-
75
-
-
55249123349
-
Cardiac dissonance without conductors: How dicer depletion provokes chaos in the heart
-
Thum T. Cardiac dissonance without conductors: how dicer depletion provokes chaos in the heart. Circulation 2008;118:1524-7.
-
(2008)
Circulation
, vol.118
, pp. 1524-7
-
-
Thum, T.1
-
76
-
-
70349254444
-
Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure
-
Rao PK, Toyama Y, Chiang HR, et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 2009;105:585-94.
-
(2009)
Circ Res
, vol.105
, pp. 585-94
-
-
Rao, P.K.1
Toyama, Y.2
Chiang, H.R.3
-
77
-
-
34247589595
-
Control of stress-dependent cardiac growth and gene expression by a microRNA
-
DOI 10.1126/science.1139089
-
van Rooij E, Sutherland LB, Qi XX, et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007;316:575-9. (Pubitemid 46683138)
-
(2007)
Science
, vol.316
, Issue.5824
, pp. 575-579
-
-
Van Rooij, E.1
Sutherland, L.B.2
Qi, X.3
Richardson, J.A.4
Hill, J.5
Olson, E.N.6
-
78
-
-
70349202176
-
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice
-
Callis TE, Pandya K, Seok HY, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009;119:2772-86.
-
(2009)
J Clin Invest
, vol.119
, pp. 2772-86
-
-
Callis, T.E.1
Pandya, K.2
Seok, H.Y.3
-
79
-
-
57749168828
-
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
-
Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-4.
-
(2008)
Nature
, vol.456
, pp. 980-4
-
-
Thum, T.1
Gross, C.2
Fiedler, J.3
-
80
-
-
78049432896
-
Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice
-
Patrick DM, Montgomery RL, Qi X, et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 2010;120:3912-6.
-
(2010)
J Clin Invest
, vol.120
, pp. 3912-6
-
-
Patrick, D.M.1
Montgomery, R.L.2
Qi, X.3
-
81
-
-
48849095818
-
MiRNA expression in the failing human heart: Functional correlates
-
Sucharov C, Bristow MR, Port JD. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol 2008;45:185-92.
-
(2008)
J Mol Cell Cardiol
, vol.45
, pp. 185-92
-
-
Sucharov, C.1
Bristow, M.R.2
Port, J.D.3
-
82
-
-
73449086958
-
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions
-
Elia L, Contu R, Quintavalle M, et al. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 2009;120:2377-85.
-
(2009)
Circulation
, vol.120
, pp. 2377-85
-
-
Elia, L.1
Contu, R.2
Quintavalle, M.3
-
83
-
-
34249279050
-
MicroRNA-133 controls cardiac hypertrophy
-
DOI 10.1038/nm1582, PII NM1582
-
Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007;13:613-18. (Pubitemid 46828487)
-
(2007)
Nature Medicine
, vol.13
, Issue.5
, pp. 613-618
-
-
Care, A.1
Catalucci, D.2
Felicetti, F.3
Bonci, D.4
Addario, A.5
Gallo, P.6
Bang, M.-L.7
Segnalini, P.8
Gu, Y.9
Dalton, N.D.10
Elia, L.11
Latronico, M.V.G.12
Hoydal, M.13
Autore, C.14
Russo, M.A.15
Dorn II, G.W.16
Ellingsen, O.17
Ruiz-Lozano, P.18
Peterson, K.L.19
Croce, C.M.20
Peschle, C.21
Condorelli, G.22
more..
-
84
-
-
22444437609
-
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis
-
DOI 10.1038/nature03817
-
Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005;436:214-20. (Pubitemid 41021266)
-
(2005)
Nature
, vol.436
, Issue.7048
, pp. 214-220
-
-
Zhao, Y.1
Samal, E.2
Srivastava, D.3
-
85
-
-
34948829119
-
The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes
-
DOI 10.1242/jcs.010728
-
Xu C, Lu Y, Pan Z, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007;120:3045-52. (Pubitemid 47517087)
-
(2007)
Journal of Cell Science
, vol.120
, Issue.17
, pp. 3045-3052
-
-
Xu, C.1
Lu, Y.2
Pan, Z.3
Chu, W.4
Luo, X.5
Lin, H.6
Xiao, J.7
Shan, H.8
Wang, Z.9
Yang, B.10
-
86
-
-
33845317603
-
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure
-
DOI 10.1073/pnas.0608791103
-
van Rooij E, Sutherland LB, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006;103:18255-60. (Pubitemid 44871645)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.48
, pp. 18255-18260
-
-
Van Rooij, E.1
Sutherland, L.B.2
Liu, N.3
Williams, A.H.4
McAnally, J.5
Gerard, R.D.6
Richardson, J.A.7
Olson, E.N.8
-
87
-
-
65249185780
-
Downregulation of MiR-199a derepresses hypoxia-inducible factor-1 alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes
-
Rane S, He MZ, Sayed D, et al. Downregulation of MiR-199a derepresses hypoxia-inducible factor-1 alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 2009;104:879-86.
-
(2009)
Circ Res
, vol.104
, pp. 879-86
-
-
Rane, S.1
He, M.Z.2
Sayed, D.3
-
88
-
-
66349123063
-
MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20
-
Ren XP, Wu JH, Wang XH, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009;119:2357-66.
-
(2009)
Circulation
, vol.119
, pp. 2357-66
-
-
Ren, X.P.1
Wu, J.H.2
Wang, X.H.3
-
89
-
-
33751173635
-
MicroRNAs modulate the angiogenic properties of HLTVECs
-
Poliseno L, Tuccoli A, Mariani L, et al. MicroRNAs modulate the angiogenic properties of HLTVECs. Blood 2006;108:3068-71.
-
(2006)
Blood
, vol.108
, pp. 3068-71
-
-
Poliseno, L.1
Tuccoli, A.2
Mariani, L.3
-
90
-
-
45549086958
-
Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210
-
Pulkkinen K, Malm T, Turunen M, et al. Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett 2008;582:2397-401.
-
(2008)
FEBS Lett
, vol.582
, pp. 2397-401
-
-
Pulkkinen, K.1
Malm, T.2
Turunen, M.3
-
91
-
-
48749130187
-
MiR-126 regulates angiogenic signaling and vascular integrity
-
Fish JE, Santoro MM, Morton SU, et al. MiR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008;15:272-84.
-
(2008)
Dev Cell
, vol.15
, pp. 272-84
-
-
Fish, J.E.1
Santoro, M.M.2
Morton, S.U.3
-
92
-
-
67649998366
-
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice
-
Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009;324:1710-13.
-
(2009)
Science
, vol.324
, pp. 1710-13
-
-
Bonauer, A.1
Carmona, G.2
Iwasaki, M.3
-
93
-
-
33748302836
-
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
-
DOI 10.1038/ng1855, PII NG1855
-
Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006;38:1060-5. (Pubitemid 44325933)
-
(2006)
Nature Genetics
, vol.38
, Issue.9
, pp. 1060-1065
-
-
Dews, M.1
Homayouni, A.2
Yu, D.3
Murphy, D.4
Sevignani, C.5
Wentzel, E.6
Furth, E.E.7
Lee, W.M.8
Enders, G.H.9
Mendell, J.T.10
Thomas-Tikhonenko, A.11
-
94
-
-
44349170706
-
Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection
-
DOI 10.1038/mt.2008.76, PII MT200876
-
Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 2008;16:1073-80. (Pubitemid 351737072)
-
(2008)
Molecular Therapy
, vol.16
, Issue.6
, pp. 1073-1080
-
-
Zincarelli, C.1
Soltys, S.2
Rengo, G.3
Rabinowitz, J.E.4
-
95
-
-
24644444609
-
Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: Role of phosphatidylinositol 3-kinase/AKT kinase
-
DOI 10.1161/CIRCULATIONAHA.104.524801
-
Kupatt C, Hinkel R, Lamparter M, et al. Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase. Circulation 2005;112:I117-22. (Pubitemid 41266662)
-
(2005)
Circulation
, vol.112
, Issue.9 SUPPL.
-
-
Kupatt, C.1
Kinkel, R.2
Lamparter, M.3
Von Bruhl, M.-L.4
Pohl, T.5
Horstkotte, J.6
Beck, H.7
Muller, S.8
Delker, S.9
Gildehaus, F.-J.10
Buning, H.11
Hatzopoulos, A.K.12
Boekstegers, P.13
-
96
-
-
1142285445
-
Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model
-
DOI 10.1016/j.cardiores.2003.11.012
-
Kupatt C, Hinkel R, Horstkotte J, et al. Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model. Cardiovasc Res 2004;61:530-7. (Pubitemid 38210158)
-
(2004)
Cardiovascular Research
, vol.61
, Issue.3
, pp. 530-537
-
-
Kupatt, C.1
Hinkel, R.2
Horstkotte, J.3
Deiss, M.4
Von Bruhl, M.-L.5
Bilzer, M.6
Boekstegers, P.7
-
97
-
-
10744232374
-
Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor-D Induces Transmural Angiogenesis in Porcine Heart
-
DOI 10.1161/01.CIR.0000115519.03688.A2
-
Rutanen J, Rissanen TT, Markkanen JE, et al. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 2004;109:1029-35. (Pubitemid 38282857)
-
(2004)
Circulation
, vol.109
, Issue.8
, pp. 1029-1035
-
-
Rutanen, J.1
Rissanen, T.T.2
Markkanen, J.E.3
Gruchala, M.4
Silvennoinen, P.5
Kivela, A.6
Hedman, A.7
Hedman, M.8
Heikura, T.9
Orden, M.-R.10
Stacker, S.A.11
Achen, M.G.12
Hartikainen, J.13
Yla-Herttuala, S.14
-
98
-
-
78650979325
-
Robust cardiomyocyte-specific gene expression following systemic injection of AAV: In vivo gene delivery follows a Poisson distribution
-
Prasad KM, Xu Y, Yang Z, et al. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther 2011;18:43-52.
-
(2011)
Gene Ther
, vol.18
, pp. 43-52
-
-
Prasad, K.M.1
Xu, Y.2
Yang, Z.3
-
99
-
-
48749117919
-
Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route
-
Baldazzi F, Jorgensen E, Ripa RS, Kastrup J. Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route. Eur Heart J 2008;29:1819-26.
-
(2008)
Eur Heart J
, vol.29
, pp. 1819-26
-
-
Baldazzi, F.1
Jorgensen, E.2
Ripa, R.S.3
Kastrup, J.4
-
100
-
-
77950962141
-
Cardiac gene therapy: Optimization of gene delivery techniques in vivo
-
Katz MG, Swain JD, White JD, et al. Cardiac gene therapy: optimization of gene delivery techniques in vivo. Hum Gene Ther 2010;21:371-80.
-
(2010)
Hum Gene Ther
, vol.21
, pp. 371-80
-
-
Katz, M.G.1
Swain, J.D.2
White, J.D.3
-
101
-
-
77951738011
-
Myocardial transfection of hypoxia inducible factor-1alpha via an adenoviral vector during coronary artery bypass grafting - A multicenter Phase i and safety study
-
Kilian EG, Sadoni S, Vicol C, et al. Myocardial transfection of hypoxia inducible factor-1alpha via an adenoviral vector during coronary artery bypass grafting - a multicenter Phase I and safety study. Circ J 2010;74:916-24.
-
(2010)
Circ J
, vol.74
, pp. 916-24
-
-
Kilian, E.G.1
Sadoni, S.2
Vicol, C.3
-
102
-
-
4444230472
-
Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery
-
DOI 10.1016/j.jacc.2004.05.074, PII S0735109704012239
-
Raake P, von Degenfeld G, Hinkel R, et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol 2004;44:1124-9. (Pubitemid 39165150)
-
(2004)
Journal of the American College of Cardiology
, vol.44
, Issue.5
, pp. 1124-1129
-
-
Raake, P.1
Von Degenfeld, G.2
Hinkel, R.3
Vachenauer, R.4
Sandner, T.5
Beller, S.6
Andrees, M.7
Kupatt, C.8
Schuler, G.9
Boekstegers, P.10
-
103
-
-
0027944524
-
Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors
-
French BA, Mazur W, Geske RS, Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 1994;90:2414-24.
-
(1994)
Circulation
, vol.90
, pp. 2414-24
-
-
French, B.A.1
Mazur, W.2
Geske, R.S.3
Bolli, R.4
-
104
-
-
0042856409
-
Catheter-based intracoronary myocardial adenoviral gene delivery: Importance of intraluminal seal and infusion flow rate
-
DOI 10.1016/S1525-0016(03)00149-7
-
Emani SM, Shah AS, Bowman MK, et al. Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. Mol Ther 2003;8:306-13. (Pubitemid 37062840)
-
(2003)
Molecular Therapy
, vol.8
, Issue.2
, pp. 306-313
-
-
Emani, S.M.1
Shah, A.S.2
Bowman, M.K.3
Emani, S.4
Wilson, K.5
Glower, D.D.6
Koch, W.J.7
-
105
-
-
77955516095
-
Delivery of gene and cellular therapies for heart disease
-
Mariani JA, Kaye DM. Delivery of gene and cellular therapies for heart disease. J Cardiovasc Transl Res 2010;3:417-26.
-
(2010)
J Cardiovasc Transl Res
, vol.3
, pp. 417-26
-
-
Mariani, J.A.1
Kaye, D.M.2
-
106
-
-
37349108621
-
Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors
-
DOI 10.1038/sj.gt.3303035, PII 3303035
-
Raake PW, Hinkel R, Muller S, et al. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther 2008;15:12-17. (Pubitemid 350284205)
-
(2008)
Gene Therapy
, vol.15
, Issue.1
, pp. 12-17
-
-
Raake, P.W.1
Hinkel, R.2
Muller, S.3
Delker, S.4
Kreuzpointner, R.5
Kupatt, C.6
Katus, H.A.7
Kleinschmidt, J.A.8
Boekstegers, P.9
Muller, O.J.10
-
107
-
-
0034619585
-
Intracoronary delivery of adenovirus encoding adenylyl cyclase VT increases left ventricular function and cAMP-generating capacity
-
Lai NC, Roth DM, Gao MH, et al. Intracoronary delivery of adenovirus encoding adenylyl cyclase VT increases left ventricular function and cAMP-generating capacity. Circulation 2000;102:2396-401.
-
(2000)
Circulation
, vol.102
, pp. 2396-401
-
-
Lai, N.C.1
Roth, D.M.2
Gao, M.H.3
-
108
-
-
0035040977
-
In vivo myocardial gene transfer: Optimization, evaluation and direct comparison of gene transfer vectors
-
DOI 10.1007/s003950170053
-
Wright MJ, Wightman LML, Lilley C, et al. In vivo myocardial gene transfer: optimization, evaluation and direct comparison of gene transfer vectors. Basic Res Cardiol 2001;96:227-36. (Pubitemid 32433057)
-
(2001)
Basic Research in Cardiology
, vol.96
, Issue.3
, pp. 227-236
-
-
Wright, M.J.1
Wightman, L.M.L.2
Lilley, C.3
De Alwis, M.4
Hart, S.L.5
Miller, A.6
Coffin, R.S.7
Thrasher, A.8
Latchman, D.S.9
Marber, M.S.10
-
109
-
-
7744222434
-
Current concepts and applications of coronary venous retroinfusion
-
DOI 10.1007/s00395-004-0486-3
-
Boekstegers P, Kupatt C. Current concepts and applications of coronary venous retroinfusion. Basic Res Cardiol 2004;99:373-81. (Pubitemid 39462359)
-
(2004)
Basic Research in Cardiology
, vol.99
, Issue.6
, pp. 373-381
-
-
Boekstegers, P.1
Kupatt, C.2
-
110
-
-
33846155891
-
Targeting the heart with gene therapy-optimized gene delivery methods
-
DOI 10.1016/j.cardiores.2006.09.021, PII S0008636306004378
-
Muller OJ, Katus HA, Bekeredjian R. Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res 2007;73:453-62. (Pubitemid 46084926)
-
(2007)
Cardiovascular Research
, vol.73
, Issue.3
, pp. 453-462
-
-
Muller, O.J.1
Katus, H.A.2
Bekeredjian, R.3
-
111
-
-
0042889037
-
Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia
-
DOI 10.1016/S0735-1097(03)00915-X
-
von Degenfeld G, Raake P, Kupatt C, et al. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J Am Coll Cardiol 2003;42:1120-8. (Pubitemid 37108604)
-
(2003)
Journal of the American College of Cardiology
, vol.42
, Issue.6
, pp. 1120-1128
-
-
Von Degenfeld, G.1
Raake, P.2
Kupatt, C.3
Lebherz, C.4
Hinkel, R.5
Gildehaus, F.J.6
Munzing, W.7
Kranz, A.8
Waltenberger, J.9
Simoes, M.10
Schwaiger, M.11
Thein, E.12
Boekstegers, P.13
-
112
-
-
34047190216
-
Endothelial Nitric Oxide Synthase Overexpression Provides a Functionally Relevant Angiogenic Switch in Hibernating Pig Myocardium
-
DOI 10.1016/j.jacc.2006.11.047, PII S0735109707003336
-
Kupatt C, Hinkel R, von Bruhl ML, et al. Endothelial nitric oxide synthase overexpression provides a functionally relevant angiogenic switch in hibernating pig myocardium. J Am Coll Cardiol 2007;49:1575-84. (Pubitemid 46517952)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.14
, pp. 1575-1584
-
-
Kupatt, C.1
Hinkel, R.2
Von Bruhl, M.-L.3
Pohl, T.4
Horstkotte, J.5
Raake, P.6
El Aouni, C.7
Thein, E.8
Dimmeler, S.9
Feron, O.10
Boekstegers, P.11
-
113
-
-
3943054801
-
Heat shock protein 90 transfection reduces ischemia-reperfusion - Induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation
-
DOI 10.1161/01.ATV.0000134300.87476.d1
-
Kupatt C, Dessy C, Hinkel R, et al. Heat shock protein 90 transfection reduces ischemia-reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation. Arterioscler Thromb Vasc Biol 2004;24:1435-41. (Pubitemid 39050437)
-
(2004)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.24
, Issue.8
, pp. 1435-1441
-
-
Kupatt, C.1
Dessy, C.2
Hinkel, R.3
Raake, P.4
Daneau, G.5
Bouzin, C.6
Boekstegers, P.7
Feron, O.8
-
114
-
-
0033993507
-
Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins
-
Boekstegers P, von Degenfeld G, Giehrl W et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther 2000;7:232-40. (Pubitemid 30113772)
-
(2000)
Gene Therapy
, vol.7
, Issue.3
, pp. 232-240
-
-
Boekstegers, P.1
Von Degenfeld, G.2
Giehrl, W.3
Heinrich, D.4
Hullin, R.5
Kupatt, C.6
Steinbeck, G.7
Baretton, G.8
Middeler, G.9
Katus, H.10
Franz, W.M.11
|